ClinicalTrials.Veeva

Menu

Pediatric Intensive Care and COVID-19 (CLOVIS)

B

Bicetre Hospital

Status

Unknown

Conditions

Infection
Critical Illness
SARS-CoV Infection
Pediatric ALL
Covid19

Study type

Observational

Funder types

Other

Identifiers

NCT04544878
PS-PICRN--20001

Details and patient eligibility

About

In this prospective longitudinal cohort the investigators reported the clinical, and biological characteristics of all critically ill patients admitted in the pediatric intensive care unit (PICU) of Bicêtre Hospital during the 2019 coronavirus disease (COVID-19) pandemics. Patients were older than 37 weeks of gestational age. No upper limit was set as the unit was transiently converted into a pediatric "adult COVID-19" intensive care unit.

Full description

All patients will be monitored during their PICU stay.

Clinical characteristics include: age, gender, co-morbidities, organ support therapies (mechanical ventilation, renal replacement therapy, extracorporeal membrane oxygenation, vasopressors), organ complications (pulmonary embolism, acute respiratory distress syndrome, renal failure, heart failure) and function, infective complications (ventilator associated pneumonia, central line associated bloodstream infection, pulmonary access, sepsis, septic shock), microbiologic and viral identification, 7-day and 28-day mortality.

Biological characteristics include:

  • Admission workup: qualitative and quantitative Ig, ferritin, creatinine kinase, complement study (C3,C4,CH50),
  • Daily workup: blood cells count, arterial blood gas analysis, lactate, electrolytes, albumin, blood urea nitrogen, creatinine, hemostasis (fibrinogen, factor V, II+VII, factor X, prothrombin time, antiXa activity, activated cephalin time, D-dimer), C-reactive protein, procalcitonin.
  • Twice weekly workup: circulating cells phenotyping (T cell and subclass including Treg, B cell, Natural Killer cell, myeloid derived suppressor cell, neutrophils), interleukin 6.
  • Bone marrow analysis when indicated by attending staff.

Enrollment

100 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients suspected or confirmed of severe acute respiratory syndrome Coronavirus 2 infection
  • No opposition from patients or legal representatives after study information
  • Patients admitted to the pediatric intensive care unit of Bicêtre Hospital, Assistance Publique Hôpitaux de Paris - Paris Saclay University
  • Between March 15, 2020 to June 31, 2021

Exclusion criteria

  • Patient or legal representative refusal to participate

Trial design

100 participants in 2 patient groups

Pediatric patients
Description:
All term children from birth to 18 years of age admitted in the PICU
Adult patients
Description:
All patients \>18 years of age

Trial contacts and locations

1

Loading...

Central trial contact

Clemence Marais, MD, MSc; Pierre Tissieres, MD, DSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems